Oncogenes and growth factor receptors as diagnostic and prognostic markers in precancers and cancers of the oral mucosa.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Current topics in pathology. Ergebnisse der Pathologie

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-642-80169-3_8PMID 8791754
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy

  2005cited by this paper
• Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas

  2004cited by this paper
• Microdissection and Molecular Genetic Analysis of HER2/neu in Breast Carcinoma

  1995cited by this paper
• BHRF1, a viral homologue of the Bcl-2 oncogene, disturbs epithelial cell differentiation.

  1995cited by this paper
• Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma.

  1995cited by this paper
• H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.

  1994cited by this paper
• Establishment of human oral‐cancer cell lines (KOSC‐2 and ‐3) carrying p53 and c‐myc abnormalities by geneticin treatment

  1994cited by this paper
• Frequent deletion of chromosome 3p in oral squamous cell carcinoma.

  1994cited by this paper
• Restriction fragment length polymorphisms of the human N-myc gene in normal healthy individuals and oral cancer patients in India.

  1994cited by this paper
• MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma.

  1994cited by this paper
• Cytogenetic findings in squamous cell carcinoma of the oral cavity.

  1994cited by this paper
• Mutations of Ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan.

  1994cited by this paper
• Co-expression of ras p21 and epidermal growth factor receptor during various stages of tumour progression in oral mucosa.

  1994cited by this paper
• Immunocytochemical localization of fibroblast growth factor-1 (FGF-1) and FGF-2 in oral squamous cell carcinoma (SCC).

  1994cited by this paper
• High incidence of H-ras oncogene mutations in squamous cell carcinoma of lip vermilion.

  1994cited by this paper
• Retinoid modulation of biomarkers in oral leukoplakia/dysplasia.

  1994cited by this paper
• Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas.

  1994cited by this paper
• Detection and cloning of potent transforming gene(s) from chewing tobacco-related human oral carcinomas.

  1994cited by this paper
• Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure.

  1994cited by this paper
• [Cell cycle arrest induced by epidermal growth factor on human squamous cell carcinoma cell lines].

  1994cited by this paper
• Interaction of transforming growth factor‐alpha and epidermal growth factor receptor in breast carcinoma. An immunohistologic study

  1994cited by this paper
• Epidermal growth factor and transforming growth factor alpha characteristics of human oral carcinoma cell lines.

  1994cited by this paper
• Molecular biology of head and neck cancer.

  1994cited by this paper
• Immunohistochemical detection of the H-ras, K-ras, and N-ras oncogenes in squamous cell carcinoma of the head and neck.

  1994cited by this paper
• Numerical aberrations of chromosome 17 detected by FISH with DNA-specific probe in oral tumors.

  1994cited by this paper
• TGF‐β receptor regulation mediates the response to exogenous ligand but is independent of the degree of cellular differentiation in human oral keratinocytes

  1994cited by this paper
• c-myc oncoprotein expression in oral precancerous and early cancerous lesions.

  1993cited by this paper
• Expression of the nm23-2/NDP kinase alpha gene in rat mammary and oral carcinoma cells of varying metastatic potential.

  1993cited by this paper
• Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis.

  1993cited by this paper
• [Expression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck].

  1993cited by this paper
• TGF-alpha and oral carcinogenesis.

  1993cited by this paper
• State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines.

  1993cited by this paper
• Activation of ribosomal protein S2 gene expression in a hamster model of chemically induced oral carcinogenesis.

  1993cited by this paper
• Immunodetection of the p21-ras products in human normal and preneoplastic tissues and solid tumors: a review.

  1993cited by this paper
• Tissue markers of potentially malignant human oral epithelial lesions.

  1993cited by this paper
• Consistent chromosomal anomalies in keratinocyte cell lines derived from untreated malignant lesions of the oral cavity

  1993cited by this paper
• Oncogenes, tumor suppressors and viruses in oral squamous carcinoma.

  1993cited by this paper
• Ras gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions.

  1993cited by this paper
• Early genetic changes during upper aerodigestive tract tumorigenesis

  1993cited by this paper
• H-ras-1 restriction fragment length polymorphism in normal individuals and oral cancer patients in India.

  1993cited by this paper
• TGF-α and oral carcinogenesis

  1993cited by this paper
• Expression of c-erbB-2 gene in human head and neck carcinoma.

  1992cited by this paper
• Immunohistochemical localization of c-myc oncogene product in oral papilloma.

  1992cited by this paper
• Multiple cytogenetic aberrations in squamous cell carcinomas of the head and neck.

  1992cited by this paper
• Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.

  1992cited by this paper
• C-erbB-2 expression in squamous cell carcinoma of the head and neck.

  1992cited by this paper
• Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck.

  1992cited by this paper
• Oral cancer progression and c-erbB-2/neu proto-oncogene expression.

  1992cited by this paper
• c-erbB-2 oncogene in breast cancer: the right target or a decoy?

  1992cited by this paper
• Point mutations in the Ha-ras oncogene are detectable in formalin-fixed tissues of oral squamous cell carcinomas, but are infrequent in British cases.

  1992cited by this paper
• Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up.

  1992cited by this paper
• c-myc oncogene copy number in squamous carcinoma of the head and neck.

  1992cited by this paper
• Gene amplification and overexpression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck

  1992cited by this paper
• Evaluation of epidermal growth factor receptor in squamous cell carcinoma of the oral cavity.

  1992cited by this paper
• [erb-B oncogene in human oral squamous cell carcinomas].

  1992cited by this paper
• Amplification and overexpression of epidermal growth factor receptor gene in human oropharyngeal cancer.

  1992cited by this paper
• Immunohistochemical detection of ras 21 in oral squamous cell carcinomas.

  1992cited by this paper
• Immunohistochemical detection of epidermal growth factor receptor in laryngeal squamous cell carcinomas.

  1992cited by this paper
• High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India.

  1991cited by this paper
• Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas

  1991cited by this paper
• Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors

  1991cited by this paper
• Gene Amplification and Gene Dosage in Cell Lines Derived From Squamous Cell Carcinoma of the Head and Neck

  1991cited by this paper
• Ras mutations in united kingdom examples of oral malignancies are infrequent

  1991cited by this paper
• Activation of the autocrine transforming growth factor alpha pathway in human squamous carcinoma cells.

  1991cited by this paper
• Analysis of gene amplification in head‐and‐neck squamous‐cell carcinomas

  1991cited by this paper
• Epidermal growth factor receptor amplification in head and neck cancer

  1991cited by this paper
• Anchorage-independent growth and the expression of cellular proto-oncogenes in normal human epidermal keratinocytes and in human squamous cell carcinoma cell lines.

  1991cited by this paper
• RAS oncogene product expression in normal and malignant oral mucosa.

  1990cited by this paper
• Oncogene amplification in squamous cell carcinoma of the head and neck.

  1990cited by this paper
• A transforming Kirsten ras oncogene in an oral squamous carcinoma.

  1990cited by this paper
• Immunohistochemical detection of ras p21 in oral papilloma.

  1990cited by this paper
• Epidermal growth factor receptors and prognosis in primary breast cancer

  1990cited by this paper
• Frequent rearrangement of chromosomal bands 1p22 and 11q13 in squamous cell carcinomas of the head and neck

  1990cited by this paper
• Immunohistochemical localization of c-myc oncogene product and EGF receptor in oral squamous cell carcinoma.

  1990cited by this paper
• Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer.

  1990cited by this paper
• Expression of epidermal growth factor receptor in breast carcinoma.

  1990cited by this paper
• Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas.

  1990cited by this paper
• Expression of c-erbB2 and c-myc in squamous epithelia and squamous cell carcinomas of the head and neck and the lower female genital tract.

  1990cited by this paper
• Amplification of the int-2 gene in human head and neck squamous cell carcinomas.

  1990cited by this paper
• Low incidence of ras oncogene activation in human squamous cell carcinomas.

  1990cited by this paper
• HER-2/neu amplification predicts poor survival in node-positive breast cancer.

  1990cited by this paper
• Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.

  1990cited by this paper
• Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.

  1990cited by this paper
• The immunohistochemical detection of ras p21 and its correlation with differentiation in oral cancers

  1989cited by this paper
• Oncogene Amplification in Squamous Cell Carcinoma of the Oral Cavity

  1989cited by this paper
• Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck.

  1989cited by this paper
• Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.

  1989cited by this paper
• Herpes simplex virus enhances the 7,12-dimethylbenz[a]anthracene (DMBA)-induced carcinogenesis and amplification and overexpression of c-erb-B-1 proto-oncogene in hamster buccal pouch epithelium.

  1989cited by this paper
• An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer.

  1989cited by this paper
• HER-2/neu oncogene protein and prognosis in breast cancer.

  1989cited by this paper
• Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines

  1989cited by this paper
• TGF-alpha and EGF-receptor mRNAs in human oral cancers.

  1989cited by this paper
• Loss of Harvey ras heterozygosity in oral squamous carcinoma.

  1989cited by this paper
• Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma.

  1989cited by this paper
• TGF-α and EGF-receptor mRNAs in human oral cancer

  1989cited by this paper
• Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.

  1989cited by this paper
• Localization of H-ras mRNA in oral squamous cell carcinomas.

  1989cited by this paper
• Predictive value of EGF receptor in breast cancer.

  1988cited by this paper
• Expression of epidermal growth factor receptor on oral squamous cell carcinoma.

  1988cited by this paper
• Onkogene bei Plattenepithelkarzinomen im Kopf-Hals-Bereich

  1988cited by this paper

• ALA-based fluorescence diagnosis of malignant oral lesions in the presence of bacterial porphyrin formation

  2006cites this paper
• Tissue and serum borne tumor markers of oral squamous cell carcinoma: present and forthcoming therapeutic roles

  2002cites this paper
• Pathologie und Prognosefaktoren von Plattenepithelkarzinomen des Kopf-Hals-Bereiches

  2001cites this paper
• Pathologie und Prognosefaktoren von Plattenepithelkarzinomen des Kopf-Hals-Bereiches

  2001cites this paper
• Prämaligne orale Veränderungen (Präkanzerosen)

  2000cites this paper
• A review of oral/pharyngeal cancer and a review of 328 cases of lingual squamous cell carcinoma

  1997influential citation
• Morphological assessment of malignant potential of epithelial hyperplastic lesions.

  1997cites this paper